Cargando…
Oral corticoid, aspirin, anticoagulant, colchicine, and furosemide to improve the outcome of hospitalized COVID-19 patients - the COCAA-COLA cohort study
Autores principales: | Kevorkian, Jean-Philippe, Lopes, Amanda, Sène, Damien, Riveline, Jean-Pierre, Vandiedonck, Claire, Féron, Florine, Nassarmadji, Kladoum, Mouly, Stéphane, Mauvais-Jarvis, Franck, Gautier, Jean-François, Mégarbane, Bruno |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The British Infection Association. Published by Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7871882/ https://www.ncbi.nlm.nih.gov/pubmed/33577902 http://dx.doi.org/10.1016/j.jinf.2021.02.008 |
Ejemplares similares
-
Early short-course corticosteroids and furosemide combination to treat non-critically ill COVID-19 patients: An observational cohort study
por: Kevorkian, Jean-Philippe, et al.
Publicado: (2021) -
No VTE Recurrence After 1-Year Follow-Up of Hospitalized Patients With COVID-19 and a VTE Event: A Prospective Study
por: Delrue, Maxime, et al.
Publicado: (2022) -
18-Fluorodeoxyglucose positron emission tomography/computed tomography for large vessel vasculitis in clinical practice
por: Nassarmadji, Kladoum, et al.
Publicado: (2023) -
OMS: Covid-19, corticoïdes mode d’emploi
por: Manus, Jean-Marie
Publicado: (2020) -
Aspirin/colchicine: Lack of efficacy: case report
Publicado: (2022)